Bias distribution and regulation in photoelectrochemical overall water-splitting cells phys.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phys.org Daily Mail and Mail on Sunday newspapers.
Daewoong Pharmaceutical has partnered with Chong Kun Dang for local sales of the gastroesophageal reflux disease (GERD) treatment Fexuclue, the country’s 34th new drug, the company said Monday. Fexuclue is a potassium-competitive acid blocker (P-CAB)-based GERD treatment that is designed to improve the shortcomings of proton pump inhibitor (PPI) drugs, such as slow onset of action and dietary effects. P-CABs ha.
Merck’s immuno-oncology drug Keytruda, one of the best-selling drugs in the world, topped drug sales in Korea for the second consecutive year in 2023, according to market tracker IQVIA on Tuesday. Keytruda’s sales in Korea came to some 399 billion won ($300 million) in 2023, up 159 billion won from the previous year, while global sales of Keytruda hit $25 billion, making it the top-selling drug worldwide..
Novartis Pharma AG: Novartis delivers strong full year performance, 10% net sales and 18% core operating income growth (cc), with margin expansion Continuing innovation momentum with multiple positive Ph3 readouts finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Korean Drug Developer Strikes Licensing Deal with Novartis chosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chosun.com Daily Mail and Mail on Sunday newspapers.